Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
GlobalData on MSN20h
Lilly reports trial results of tirzepatide for treating obesity and pre-diabetesEli Lilly has reported comprehensive outcomes from the SURMOUNT-1 study of tirzepatide (Zepbound and Mounjaro) for treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback